BOXIT

A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder

Existing samples:

  • Carcinoma in situ of bladder

Contact Information

Email:
boxit-icrctsu@icr.ac.uk
Address:

ICR-CTSU, Division of Clinical Studies
Sir Richard Doll Building
Cotswold Road
Sutton
Surrey
Surrey
CR0 6NS
UK

Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A